Wasn't someone from Gilead on Amarex "helping" us with our CD12 trial? This investigation appears to be very much like the FDA letter that had to have been written by a BP colleague just as we moved out of FDA control to foreign trials, and this just as Brazil is to start!

This is very weird. The intent is plain, tie up CytoDyn long enough before approval to run it out of business before Leronlimab can be approved. The whole thing is about control of Leronlimab, has been from the beginning.